Health Final Terms

Front 1

Zoonotic disease

Back 1

Viral and bacterial diseases transmitted to humans by arthropods,
primarily mosquitoes, ticks, and fleas.

Front 2

Vector-borne disease

Back 2

Viral and bacterial diseases transmitted to humans by arthropods,
primarily mosquitoes, ticks, and fleas.

Front 3

Vaccines

Back 3

Biological substances used to stimulate the development of antibodies and
thus confer active immunity against a specific disease or number of diseases.

Front 4

Vaccine Adverse Event Reporting System (VAERS).

Back 4

A passive surveillance system
that monitors vaccine safety by collecting and analyzing reports of adverse events following
immunization from vaccine manufacturers, private practitioners, State and local public
health clinics, parents, and individuals who receive vaccines. CDC and the Food and Drug
Administration work together to implement VAERS

Front 5

Surveillance regions:

Back 5

The nine regions of the United States used for influenza surveillance
purposes.

Front 6

Reportable disease

Back 6

A disease for which there are legal requirements for reporting and
notification to public health authorities. In the United States, requirements for reporting
diseases are mandated by State laws or regulations, and the list of reportable diseases in
each State differs.

Front 7

Reemerging infectious diseases

Back 7

Reappearance of a known infection after a decline in
occurrence. Reemergence of “old” infectious agents can be the result of lapses in public
health measures, changes in human behavior that increase person-to-person transmission
of infectious agents, changes in food handling or eating habits, or changes in the way
humans interact with their environment.

Front 8

Penicillin resistant

Back 8

Having a minimum inhibitory concentration (MIC) equal to or greater
than 2 µg/ml. Strains with “intermediate” susceptibility are not included in this category.

Front 9

Patient day

Back 9

A day or part of a day for which a patient was hospitalized.

Front 10

National Notifiable Disease Surveillance System (NNDSS)

Back 10

Tracking system that State
health departments use to report cases of selected diseases to CDC. (See Reportable
disease).

Front 11

Multiple sex partners

Back 11

More than one partner in the prior 6 months.

Front 12

Latent TB infection

Back 12

The state of being infected with the organism Mycobacterium tuberculosis but without signs or symptoms of active TB disease.

Front 13

Invasive pneumococcal infection

Back 13

Isolating the bacteria Streptococcus pneumoniae
from a normally sterile site, including blood, cerebrospinal fluid, or pleural fluid.

Front 14

Hospital-acquired infection

Back 14

Any infection that a patient acquires as a result of medical
treatment while in the hospital.

Front 15

Group immunity

Back 15

The immunity of a group or community. Immunity based on the resistance
to infection among a high proportion of individual members of the group.

Front 16

Invasive group B streptococcal disease: Isolation of group B Streptococcus from a
normally sterile site, such as blood or cerebrospinal fluid.

Back 16

Isolation of group B Streptococcus from a
normally sterile site, such as blood or cerebrospinal fluid.

Front 17

Early onset of group B streptococcal diseaseage.

Back 17

Illness onset at less than 7 days of

Front 18

Group B Streptococcus (GBS)

Back 18

A normal germ found in the intestines and on the genitals
of about one out of five pregnant women. GBS is usually not harmful to the woman
carrying the germ but it can cause dangerous infections in the blood, spinal fluid, and
lungs of babies born to these women.

Front 19

Page 14-52 Healthy People 2010

Back 19

Objectives for Improving Health
population for the first time, the disease has been detected for the first time, or links between
an infectious agent and a chronic disease or syndrome have only recently been
identified.

Front 20

Emerging infectious diseases

Back 20

Diseases of infectious origin whose occurrence in humans
has increased within the past two decades or threatens to increase in the near future.
Recognition of an emerging disease occurs because the disease is present in the

Front 21

Distant infection

Back 21

The spread of infection in a patient from one anatomic site to another
site in the body, such as through the blood stream from the lungs to the liver or brain.

Front 22

Conjugate vaccine

Back 22

A type of inactivated vaccine composed of fractions of bacteria
linked to a protein. This linkage makes the vaccine more potent.

Front 23

Comprehensive primary care:

Back 23

All aspects of routine health care (preventive, diagnostic,
and therapeutic) delivered by a trained health care provider.

Front 24

Complete curative therapy:

Back 24

Full course of recommended treatment.

Front 25

Common cold:

Back 25

Defined based on International Classification of Disease (ICD)-9


diagnostic
codes 460.0, 461.0, 465.0, 465.8, 465.9, and 472.0.

Front 26

Colonization:

Back 26

The establishment of a colony or growth of an organism in a patient, typically
in a nonsterile anatomic site such as the skin, nasal mucosa, or colon.

Front 27

Advisory Committee on Immunization Practices (ACIP): Federally chartered advisory
Committee with the goals of providing advice to the CDC Director on decreasing disease
Through the use of vaccines and other biological products and on improving the safety of
their use.

Back 27

Federally chartered advisory
Committee with the goals of providing advice to the CDC Director on decreasing disease
Through the use of vaccines and other biological products and on improving the safety of
their use.